Search Results - "Redondo, Alba María"

Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity by Jiménez‐Solas, Tamara, López‐Cadenas, Félix, Aires‐Mejía, Irene, Caballero‐Berrocal, Juan Carlos, Ortega, Rebeca, Redondo, Alba María, Sánchez‐Guijo, Fermín, Muntión, Sandra, García‐Martín, Luís, Albarrán, Beatriz, Alonso, José María, Del Cañizo, Consuelo, Hernández‐Hernández, Ángel, Díez‐Campelo, María

“…Summary Patients with low‐risk myelodysplastic syndromes (MDS) usually develop iron overload. This leads to a high level of oxidative stress in the bone marrow…”
Get full text

Efficacy of Autologous Stem-Cell Transplantation in Patients with Relapsed or Refractory Aggressive B-Cell Lymphoma in the Rituximab Era. A Multicenter Geltamo Study by Redondo, Alba María, Martín, Alejandro, Pomares, Helena, Vidal, María Jesús, Pascual, María Jesús, Quereda, Beatriz, Sancho, Juan Manuel, Díaz-Mediavilla, Joaquín, López, Javier, Conde, Eulogio, Jarque, Isidro, Alonso, Natalia, Ramirez, María José, Sayas, María José, Requena, María José, Salar, Antonio, González, José David, González-Barca, Eva, Arranz, Reyes, Miguel, Jesús F San, Caballero, Dolores

“…Abstract 3142▪▪This icon denotes a clinically relevant abstract Recent studies indicate that the use of highly effective rituximab (R)-containing primary…”
Get full text

Lenalidomide In Combination With R-ESHAP (LR-ESHAP) In Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma Candidates To Autologous Stem-Cell Transplantation: A Phase 1b Study From Spanish Group Geltamo by Martín, Alejandro, Redondo, Alba María, López-Guillermo, Armando, Salar, Antonio, González-Barca, Eva, Canales, Miguel, Caballero, Dolores

“…Diffuse large B-cell lymphoma (DLBCL) patients with relapsed or refractory disease after rituximab-containing first-line therapy have a poor outcome with the…”
Get full text

A Phase 2 Study from Spanish Geltamo Group Investigating the Efficacy and Safety of Bendamustine As Part of Conditioning Regimen for Autologous Stem-Cell Transplantation in Patients with Aggressive Lymphomas: Second Interim Analysis by Martín, Alejandro, Redondo, Alba María, Valcárcel, David, Gonzalez, Ana Pilar, López-Guillermo, Armando, Bello, José Luis, Canales, Miguel A., Gayoso, Jorge, Conde, Eulogio, Jarque, Isidro, Del campo, Raquel, Arranz, Reyes, Terol, María-José, Rifon, Jose J., Rodríguez, María-José, Ramírez, María-José, Grande, Carlos, Sánchez, Andrés, López-Jiménez, Javier, Caballero, Dolores

“…High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard treatment for patients with relapsed or refractory aggressive…”
Get full text